Stocks

ANCN Stock: Speculation Around Investor Letter Sends Anchiano Therapeutics Soaring

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Anchiano Therapeutics (NASDAQ:ANCN) stock is rocketing higher on Monday after a shareholder letter caught the interest of investors.

The letters "M&A" on a wooden table, surrounded by a calculator and other business items. mergers and acquisitions

Source: Shutterstock.com

The letter being sent to shareholders details a special meeting taking place on March 15. The head of the letter notes that the meeting is for a proposed merger vote that will affect shareholders’ investment in the company.

$ANCN March 15th 🤑🤑🤑 pic.twitter.com/WPFJCngvCW

— Potato Chip Daddy (@PotatoChipDaddy) March 8, 2021

With the merger vote date confirmed, investors piling into Anchiano Therapeutics ahead of time. As of this writing, more than 31 million shares of ANCN stock have change hands. To put that in perspective, the company’s daily average trading volume is about 2.9 million shares.

Anchiano Therapeutics announced back in December plans to merge with Chemomab. Ever since then, the stock has been performing well with investors showing a positive reaction to the merger news.

The merger will have the management team of the combined company mostly made up of leaders from Chemomab. However, ANCN CEO Neil Cohen will serve on its Board of Directors.

It’s also worth pointing out that Anchiano Therapeutics started clinical trials for one of its treatments last month. This has it working to treat liver, skin, and lung fibrosis-related diseases. That means it’s getting closer to approval from the U.S. Food and Drug Administration (FDA) for its treatment.

Other investors on social media are also showing their love for the merger news on social media.

$ANCN, beautiful chart price action. Was in at 5.30 and sold at 6.09 but I have feeling I'll be kicking myself later

— Neurons_on_Fire (@NeuronsOn) March 8, 2021

$ANCN 🛌

How comfortable is that bed, haters? pic.twitter.com/XyfqeXTKDH

— DBR 💎 (@dabullrunner) March 8, 2021

$ANCN team is making 💰💰💰🔥🔥🔥
LFG #gme $amc $aapl $tsla $nakd $nak $bb $aal $f $nio $cciv $visl $trch $zom $gnus $sndl $trch $sndl $ONTX $ITRM $QQQ $spy $rkt $pltr $tlry $insg $eyes https://t.co/j0NzpQ9C1Z pic.twitter.com/DXg624SVmJ

— real time stock alerts (@stocksalerter11) March 8, 2021

$ANCN on fire PM! 🔥 🚀 pic.twitter.com/dMYWklBOiv

— Goofers (@Goofers212) March 8, 2021

ANCN stock was up 78.4% as of Monday morning and is up 252.3% since the start of the year.

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article.

The post ANCN Stock: Speculation Around Investor Letter Sends Anchiano Therapeutics Soaring appeared first on InvestorPlace.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CMMB

Latest Stocks Videos

JPMorgan Says Buy the Dip as Investors Face Volatility

Dec 02, 2021

InvestorPlace

InvestorPlace is one of America’s largest, longest-standing independent financial research firms. Started over 40 years ago by a business visionary named Tom Phillips, we publish detailed research and recommendations for self-directed investors, financial advisors and money managers.

Learn More